FDA Releases Guidances on Transition Plan for Devices Distributed Under Emergency Use Authorization (EUA) or Enforcement Policies During COVID-19 (JSON)

lexblog.com/lib/AFKE3YVHview recordjson

{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "FDA Releases Guidances on Transition Plan for Devices Distributed Under Emergency Use Authorization (EUA) or Enforcement Policies During COVID-19",
    "url": "https://www.lexblog.com/2022/01/13/fda-releases-guidances-on-transition-plan-for-devices-distributed-under-emergency-use-authorization-eua-or-enforcement-policies-during-covid-19-2/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-AFKE3YVH",
        "url": "https://www.lexblog.com/lib/AFKE3YVH/"
    },
    "datePublished": "2022-01-13T12:02:57-05:00",
    "dateModified": "2023-03-08T16:45:48-05:00",
    "author": {
        "@type": "Person",
        "name": "Keeley A. McCarty, Elizabeth Hummel*"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Sheppard, Mullin, Richter & Hampton LLP"
    },
    "organizationScope": "at-publication",
    "about": "Food, Drug & Agriculture",
    "sourceUrl": "https://www.fdalawblog.com/?p=1792",
    "sourceStability": "may-move"
}